GPC3 and hepatocellular carcinoma: Third, focal GPC3 immunoreactivity has been documented in 11% of regenerative nodules in cirrhotic livers, necessitating strict correlation with morphological features to avoid overdiagnosis of well-differentiated HCC [31].